Sichuan Hexie Shuangma (000935.SZ) holding subsidiary Hubei Jianxiang passed the on-site inspection by the US FDA.

Sichuan Hexie Shuangma (000935.SZ) announced that its subsidiary, Hubei Jianxiang Biopharmaceutical Co., Ltd. ("Hubei Jianxiang"), has received an on-site inspection report from the US FDA. According to the inspection report, Hubei Jianxiang's quality and production systems meet the standards of the US FDA and have passed the on-site inspection.